- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06567574
Stanford PIPRA Validation Study in an Elderly Orthopedic Population (PIPRA-ORTHO)
Stanford Study of the Validation of the Pre-Interventional Preventive Risk Assessment (PIPRA) Tool In The At-Risk Orthopedic Surgery Population
Study Overview
Status
Conditions
Detailed Description
Study investigators would like to determine the real-life accuracy of a new tool developed for the prediction of delirium: Pre-Interventional Preventive Risk Assessment (PIPRA) Tool. The importance of assessing the risk for post-operative delirium (POD) includes: providing clinicians and patients with accurate predictive information regarding the patient's risk for developing delirium as part of the risk/benefit calculation for surgical procedures, and thus potential risk of subsequent cognitive impairment; as well as the ability to introduce timely prophylactic techniques that may prevent its onset.
The PIPRA tools consists of nine items commonly found in any presurgical patient's electronic medical record (EMR). The tool has been designed to run in the background of the EMR and automatically calculate the patient's risk for developing delirium upon admission for surgical intervention. For our study, we will be applying the PIPRA tool to the EMR of patients already enrolled in a parallel study as detailed above.
The PIPRA tool predicts the risk of developing POD delirium based on its algorithm that takes into consideration the following nine clinical variables: age, height/weight or body mass index, the American Society of Anesthesiologist physical status Classification system (ASA), past history of delirium, past history of cognitive impairment (including dementia), number of medications, preoperative C-reactive protein levels, surgical risk (as determined by the European Society of Anesthesiology), and type of surgery. The subsequent result predicts the risk (in percentage) of a patient developing POD following surgery.
The PIPRA tool is fully integrated into EMR systems, operating in the background, extracting relevant information, and automatically generating a delirium prediction score. In addition, this software possesses the flexibility to recalibrate the delirium risk based on the availability of the nine clinical variables.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
California
-
Palo Alto, California, United States, 94304
- Stanford Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Surgical patients
- Greater than or equal to 65 years old
- ASA I, II or III
- Greater than 90 min of surgery
- Non-cardiac surgery
Exclusion Criteria:
- Dementia
- Alzheimer's
- Parkinson's
- Current Benzodiazepine use
- Alcoholism
- Previous surgery within the last 12 months or expected in the 12 months to come (except the expected surgery for which they are being enrolled).
- Color-blindness
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of subjects with postoperative delirium accurately predicted by the PIPRA Tool
Time Frame: Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively
|
Assessment of the accuracy on the prediction of subjects identified as developing delirium by the PIPRA tool, as compared with post-operative standardized delirium assessment tools.
We will compare the assessment of the PIPRA prediction tool (performed pre-op) with the actual development of delirium as assessed by a clinical assessment based on DSM; the CAM-ICU & SPTD assessment tools.
|
Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively
|
|
Development of post-operative Delirium
Time Frame: Up to 72 hours post-operatively
|
Number of subjects diagnosed with post-operative delirium
|
Up to 72 hours post-operatively
|
|
Determination of Delirium Phenotype
Time Frame: Up to 72 hours post-operatively.
|
For those who develop delirium, the phenotype of delirium will be determined as per the Liptzin-Levkoff Criteria (based on DSM diagnostic Criteria).
As such, all delirium episodes will be categorized as: hyperactive, hypoactive, mixed, or subsyndromal delirium.
|
Up to 72 hours post-operatively.
|
|
Impact of delirium on post-operative cognitive impairment
Time Frame: Up to 10-year post-operatively.
|
Impact of delirium occurrence and emergence of cognitive impairment post-operatively
|
Up to 10-year post-operatively.
|
|
Sensitivity and specificity of the PIPRA tool for detecting postoperative delirium.
Time Frame: Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively
|
Sensitivity and specificity of various cut off points of the PIPRA tool for detecting postoperative delirium.
|
Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively
|
|
Receiver operating characteristic (ROC) curve analysis of PIPRA tool
Time Frame: Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively
|
Receiver operating characteristic (ROC) curve analysis of PIPRA tool
|
Baseline measurement of variables and detection of delirium presenting up to 72 hours post-operatively
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Discharge Site
Time Frame: Type of facility the patient was discharge to from the hospital (assessed up to 6 months from admission)
|
Site of discharge (e.g., home, rehabilitation, skilled nurse facility, etc)
|
Type of facility the patient was discharge to from the hospital (assessed up to 6 months from admission)
|
|
Requirement of Intensive Care Unit Admission
Time Frame: Time to discharge from the hospital (assessed up to 6 months from admission)
|
Need for admission to an intensive care unit due to clinical necessity or deterioration
|
Time to discharge from the hospital (assessed up to 6 months from admission)
|
|
Immediate Postoperative Mortality
Time Frame: From date of post-operative admission up to time of postoperative discharge, an average of 72 hours.
|
Mortality rate immediately after index surgery
|
From date of post-operative admission up to time of postoperative discharge, an average of 72 hours.
|
|
Length of Hospital Length of Stay
Time Frame: From date of post-operative admission up to time of postoperative discharge (assessed up to 1 year after admission).
|
Total number of days admitted to the hospital
|
From date of post-operative admission up to time of postoperative discharge (assessed up to 1 year after admission).
|
|
Need of pharmacological protocol
Time Frame: From post-operative hospital admission up to time of postoperative discharge (assessed up to 6 months from admission)
|
Need of pharmacological protocol for management of delirium
|
From post-operative hospital admission up to time of postoperative discharge (assessed up to 6 months from admission)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: José R Maldonado, MD, Stanford University
Publications and helpful links
General Publications
- Buchan TA, Sadeghirad B, Schmutz N, Goettel N, Foroutan F, Couban R, Mbuagbaw L, Dodsworth BT. Preoperative prognostic factors associated with postoperative delirium in older people undergoing surgery: protocol for a systematic review and individual patient data meta-analysis. Syst Rev. 2020 Nov 14;9(1):261. doi: 10.1186/s13643-020-01518-z.
- Dodsworth BT, Reeve K, Falco L, Hueting T, Sadeghirad B, Mbuagbaw L, Goettel N, Schmutz Gelsomino N. Development and validation of an international preoperative risk assessment model for postoperative delirium. Age Ageing. 2023 Jun 1;52(6):afad086. doi: 10.1093/ageing/afad086.
- Sadeghirad B, Dodsworth BT, Schmutz Gelsomino N, Goettel N, Spence J, Buchan TA, Crandon HN, Baneshi MR, Pol RA, Brattinga B, Park UJ, Terashima M, Banning LBD, Van Leeuwen BL, Neerland BE, Chuan A, Martinez FT, Van Vugt JLA, Rampersaud YR, Hatakeyama S, Di Stasio E, Milisen K, Van Grootven B, van der Laan L, Thomson Mangnall L, Goodlin SJ, Lungeanu D, Denhaerynck K, Dhakharia V, Sampson EL, Zywiel MG, Falco L, Nguyen AV, Moss SJ, Krewulak KD, Jaworska N, Plotnikoff K, Kotteduwa-Jayawarden S, Sandarage R, Busse JW, Mbuagbaw L. Perioperative Factors Associated With Postoperative Delirium in Patients Undergoing Noncardiac Surgery: An Individual Patient Data Meta-Analysis. JAMA Netw Open. 2023 Oct 2;6(10):e2337239. doi: 10.1001/jamanetworkopen.2023.37239.
- Maldonado JR. Acute Brain Failure: Pathophysiology, Diagnosis, Management, and Sequelae of Delirium. Crit Care Clin. 2017 Jul;33(3):461-519. doi: 10.1016/j.ccc.2017.03.013.
- Robinson TN, Eiseman B. Postoperative delirium in the elderly: diagnosis and management. Clin Interv Aging. 2008;3(2):351-5. doi: 10.2147/cia.s2759.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-73341
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Delirium
-
Alexandria UniversityCompletedClozapine Poisoning | Hypoactive Delirium | Tricyclic Antidepressant Poisoning | Anticholinergic Delirium | Antipsychotic Toxicity | CNS Depression | Procyclidine Induced DeliriumEgypt
-
Efficacy Care R&D LtdHadassah Medical OrganizationUnknownDelirium | Delirium, Cause Unknown | Delirium of Mixed Origin | Delirium Confusional State | Delirium Drug-InducedIsrael
-
Duke UniversityNot yet recruitingDelirium Confusional State | Hyperactive Delirium | Delirium in the Intensive Care Unit | Agitated DeliriumUnited States
-
Imperial College Healthcare NHS TrustRecruitingCardiac Surgery | Intensive Care Unit Delirium | Post Operative DeliriumUnited Kingdom
-
Sengkang General HospitalRecruitingDelirium and Post-operative Cognitive Dysfunction (POCD) | Delirium, Postoperative | Delirium - PostoperativeSingapore
-
Oslo University HospitalUniversity of Melbourne; Norwegian Academy of MusicCompletedDelirium in Old Age | Delirium of Mixed Origin | Delirium Superimposed on Dementia | Delirium Confusional StateNorway
-
Universitat de LleidaHospital d'IgualadaNot yet recruitingDelirium in Old Age | Delirium Treatment | Delirium Confusional StateSpain
-
Universidad de SantanderUnknownDelirium of Mixed Origin | Hypoactive Delirium | Hyperactive DeliriumColombia
-
Wonkwang University HospitalCompleted
-
Second Affiliated Hospital of Wenzhou Medical UniversityAffiliated Wenling Hospital of Wenzhou Medical UniversityRecruitingInjection | Delirium in Old Age | Post Operative Delirium | Non-cardiac SurgeryChina